| Type | Public |
| HQ | Lexington, US |
| Founded | 1994 |
| Size (employees) | 255 (est) |
| Website | agenusbio.com |
Agenus was founded in 1994 and is headquartered in Lexington, US
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Agenus
Garo Armen
PhD, Chairman and CEO
Jennifer Buell
PhD, Chief Communications and External Affairs Officer
Ozer Baysal
Chief Commercial Officer and Head of Human Resources
Michael Plater
PhD, Chief Business Officer
Alex Duncan
PhD, Chief Technology Officer and Head of Research
Christian Cortis
PhD, Chief Strategy Officer & Head of Finance
Report incorrect company information
Agenus Office Locations
Agenus has offices in Cambridge, Berkeley, New York and Lexington
Lexington, US (HQ)
3 Forbes Road
Berkeley, US
793 Heinz Ave
New York, US
149 Fifth Ave. Suite 500
Cambridge, GB
315 Science Park Milton Road
Report incorrect company information
Agenus Financials and Metrics
Agenus Revenue
Agenus's revenue was reported to be $42.88 m in FY, 2017
| USD | |
|---|---|
Revenue (Q2, 2018) | 17.5 m |
Net income (Q2, 2018) | (79.5 m) |
EBIT (Q2, 2018) | (58.3 m) |
Market capitalization (20-Sep-2018) | 237.9 m |
Closing stock price (20-Sep-2018) | 2.1 |
Cash (30-Jun-2018) | 43.2 m |
EV | 207.8 m |
Agenus's current market capitalization is $237.9 m.
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 736 k | 720.9 k | 3.1 m | 1.6 m | 4 m | 6.4 m | 6.8 m | 6 m | 6.6 m | 4.4 m | 27 m | 4.2 m | 1.6 m | 17.5 m |
General and administrative expense | 3.6 m | 5.2 m | 5.8 m | 4.9 m | 5.5 m | 8 m | 6.4 m | 9.2 m | 7.1 m | 8.1 m | 7.8 m | 8.1 m | 8.9 m | 18.4 m |
R&D expense | 3.9 m | 4.5 m | 5.2 m | 5.3 m | 9.2 m | 24.8 m | 18.5 m | 5.8 m | 6.6 m | 4.4 m | 27 m | 4.2 m | 29.4 m | 58.7 m |
Operating expense total | 7.5 m | 9.6 m | 11.1 m | 10.2 m | 14.7 m | 32.8 m | 24.9 m | 15 m | 13.7 m | 12.6 m | 34.7 m | 12.3 m | 38.4 m | 77.1 m |
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 30.2 m | 73.5 m | 48.3 m | 38.4 m | 79.3 m | 124.7 m | 184.1 m | 78.3 m | 73.4 m | 75.4 m | 113.9 m | 81.8 m | 52.3 m | 43.2 m |
Accounts Receivable | 1.1 k | 2.5 m | 4.1 m | 7.3 m | 10.2 m | 9.4 m | 10.3 m | 6.8 m | 3.9 m | 1.1 m | 10.9 m | |||
Inventories | 3.3 k | 95.7 k | 95.7 k | 88.2 k | 88.2 k | 88.2 k | 88.2 k | 88.2 k | 88.2 k | 87.5 k | 87 k | 62.2 k | 55.5 k | |
Current Assets | 30.9 m | 75.3 m | 67 m | 55.2 m | 85.2 m | 146.3 m | 208.9 m | 161.6 m | 136.1 m | 109.5 m | 138 m | 110.7 m | 65.2 m | 67.7 m |
Annual
Quarterly
| USD | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q1, 2018 | Q2, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (24.3 m) | (357.5 k) | (8.4 m) | (16.5 m) | (18.7 m) | (59.2 m) | (13.1 m) | (31.8 m) | (28.3 m) | (40.8 m) | (17.1 m) | (54.3 m) | (79.5 m) |
Depreciation and Amortization | 448.2 k | 266.5 k | 589.4 k | 1 m | 445.5 k | 885.5 k | 1.6 m | 3.1 m | |||||
Inventories | 12.7 k | (95.7 k) | (95.7 k) | 7.5 k | 7.5 k | 88.2 k | 88.2 k | 88.2 k | 88.2 k | 87.5 k | 17.3 k | 24 k | |
Accounts Payable | (269.4 k) | 184 k | (562.1 k) | 35.2 k | 2.3 m | 797.8 k | 3.1 m | 2.5 m | 5 m | 3.3 m | 4.8 m | (2.8 m) | 1.7 m |
| USD | Y, 2018 |
|---|---|
EV/EBIT | -3.6 x |
EV/CFO | -2.9 x |
Financial Leverage | -1.2 x |
Report incorrect company information
Agenus Online and Social Media Presence
1.01k Twitter followers
Agenus has 1.01k Twitter Followers. The number of followers has increased 4.9% month over month and decreased 13.7% quarter over quarter
Report incorrect company information
Agenus News and Updates
September 17, 2018
Agenus Receives Milestone Payment from Incyte
LEXINGTON, Mass., Sept. 17, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced today receipt of a cash milestone from Incyte for the initiation of a...
September 04, 2018
Agenus to Present at The Annual B. Riley FBR Healthcare Conference in New York City
LEXINGTON, Mass., Sept. 4, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced today that Jennifer Buell, Ph.D., Chief Communications and External Affairs ...
August 15, 2018
Agenus Receives Second Milestone Payment from Merck
LEXINGTON, Mass., Aug. 15, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with a pipeline of immune checkpoint antibodies, cancer vaccines and adoptive cell therapies1, announced today that Merck, known as MSD outside the United States and Canada,...
August 02, 2018
Agenus to Report Second Quarter 2018 Financial Results on August 9, 2018 and Host Conference Call and Webcast
LEXINGTON, Mass., Aug. 2, 2018 /PRNewswire/ -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune checkpoint antibodies, cancer vaccines, and adoptive cell therapies1, will release its second quarter 2018 financial results before the market opens on Thursday, ...
July 25, 2018
Pre-Market Research Reports on Biotech Stocks -- Agenus, Aimmune Therapeutics, Akebia Therapeutics, and Alder Biopharma
NEW YORK, July 25, 2018 /PRNewswire/ -- If you want a free Stock Review on AGEN, AIMT, AKBA, and ALDR sign up now at https://stocktraderreport.com/registration/. On Tuesday, key US indices were mixed as the NASDAQ Composite finished the trading session down 0.01%; the Dow Jones Industrial ...
May 18, 2018
Agenus: Buy, Sell Or Hold?
Report incorrect company information
Agenus Company Life and Culture
Report incorrect company information